Aehr Test Systems receives silicon photonics production order
Aehr Test Systems has received a silicon photonics production order, signaling early commercial traction in a newer end-market beyond its core SiC wafer-level burn-in business. Against a backdrop of declining revenues (-10.9% YoY) and a net loss, the order is a potential inflection catalyst but the financial picture remains fragile.
What happened
Aehr Test Systems has received a silicon photonics production order, signaling early commercial traction in a newer end-market beyond its core SiC wafer-level burn-in business.
The read · Jul 9
AEHR received a silicon photonics production order — the question is whether this new vertical is large enough and fast enough to offset the ongoing SiC revenue decline and return the company to growth.
Wrong if
If the order is a small pilot or single-customer test, silicon photonics fails to scale as a revenue driver and core SiC spending remains depressed — the financial losses deepen with no catalyst to re-rate the stock higher.
CoverageSource: Investing.com · Published here THU, JUL 9 · 7:36 AM ET · the only report in this recordHow this is decided →
The chart · AEHRTradingView · third-party feed, not the Wire’s licensed closes
🔒 Click to interact · scroll moves the page
The story1 min read
Aehr Test Systems (AEHR) has secured a silicon photonics production order, marking a meaningful step in the company's effort to diversify beyond silicon carbide (SiC) power device testing, which has been its primary revenue driver. The headline is light on specifics — no customer name, no dollar value, and no delivery timeline have been disclosed publicly.
The backdrop is challenging: Aehr's most recent fiscal year (ending May 2025) showed revenues of $59M, down nearly 11% year-over-year, with the company running a negative net margin of -6.6% and diluted EPS of -$0.13. Gross margins at ~40% remain respectable for a capital equipment name, but the top-line deterioration reflects a slowdown in SiC customer capex.
Silicon photonics is a genuine growth vector — driven by AI data center interconnect demand and co-packaged optics — and Aehr's wafer-level test-and-burn-in expertise is architecturally relevant. A production order (vs. an evaluation or qualification order) is a positive signal, as it implies a customer has cleared the qualification gate and is committing to volume.
The bull case hinges on whether silicon photonics becomes a meaningful revenue contributor fast enough to offset SiC headwinds and restore growth. The bear case is that with no disclosed financials around the order, it could be a small pilot that moves little, while the core business continues to drag on results.
Key things to watch: any customer or volume disclosure, next quarterly earnings for revenue guidance revision, and broader silicon photonics capex signals from hyperscalers and optical module makers.
The read, in fullWhy it matters
A production-level silicon photonics order signals Aehr has cleared customer qualification in a high-growth AI-adjacent market; if it represents even $5-10M in incremental revenue it would be material against a $59M base. The stock's depressed valuation (loss-making, revenue declining) means positive revenue inflection could drive a sharp re-rating. However, with no order size disclosed, the magnitude is entirely uncertain.
The arc● Open · no developments yet
· Published
The read above, as written. kept as written · closes shown from JUL 9 on
Next · what would move this
4-8 weeks, into next earnings print. Follow to be told when one lands.
Since this story · named here, equal weight · 1D EOD+13.2%
JUL 9 · first close after publicationSEP 4
Price context does not establish that the story caused the move.
▲ The case it holds
A production order (not a qualification trial) in silicon photonics — a market driven by AI datacenter interconnect demand — suggests Aehr is entering a volume ramp phase in a vertical with structural tailwinds, potentially reversing the -10.9% revenue trend.
▼ The case it breaks
With revenues already declining 10.9% YoY, a net loss of -$0.13 EPS, and zero disclosed financials around the order, there is a credible risk the silicon photonics win is a small-dollar engagement that does not move the needle on the company's deteriorating financial trajectory.
Kept as written · your side, if you take one, is graded privately against licensed closes after 10 trading days · nothing here is advice · How the Wire is made →